The management of prostatic carcinoma : an international perspective, June 1, 1990, Toronto, CanadaTRACHTENBERG, John.Seminars in oncology. 1991, Vol 18, Num 5, issn 0093-7754, 27 p., SUP6Conference Proceedings

Looking to the future: Advances in the management of hormone-refractory prostate cancerTRACHTENBERG, John; BLACKLEDGE, George.European urology. Supplement. 2002, Vol 1, Num 7, pp 44-53, issn 1569-9056, 10 p.Article

Epirubicin plus flutamide and orchidectomy in previously untreated advanced prostatic cancerPUMMER, K.Seminars in oncology. 1991, Vol 18, Num 5, pp 26-28, issn 0093-7754, SUP6Conference Paper

Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progressionTRACHTENBERG, John.BJU international. Supplement (Print). 2005, Vol 95, Num 4, pp 6-11, issn 1465-5101, 6 p.Article

Carcinoma of the prostate : general conceptsRIOJA, L. A; SANZ, J.Seminars in oncology. 1991, Vol 18, Num 5, pp 2-8, issn 0093-7754, SUP6Conference Paper

Male BRCAI and BRCA2 mutation carriers : A pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinicHORSBURGH, Sheri; MATTHEW, Andrew; BRISTOW, Robert et al.The Prostate. 2005, Vol 65, Num 2, pp 124-129, issn 0270-4137, 6 p.Article

Cardiovascular effects of androgen depletion and replacement therapyPINTHUS, Jehonathan H; TRACHTENBERG, John; KLOTZ, Laurence et al.Urology (Ridgewood, NJ). 2006, Vol 67, Num 6, pp 1126-1132, issn 0090-4295, 7 p.Article

Flutamide monotherapy as primary treatment in advanced prostatic carcinomaDELAERE, K. P. J; VAN THILLO, E. L.Seminars in oncology. 1991, Vol 18, Num 5, pp 13-18, issn 0093-7754, SUP6Conference Paper

Combined treatment (goserelin plus flutamide) versus monotherapy (goserelin alone) in advanced prostate cancer : a randomized studyJURINCIC, C. D; HORLBECK, R; KLIPPERL, K.-F et al.Seminars in oncology. 1991, Vol 18, Num 5, pp 21-25, issn 0093-7754, SUP6Conference Paper

Obesity Is Associated With Larger Prostate Volume but not With Worse Urinary Symptoms: Analysis of a Large Multiethnic CohortBHINDI, Bimal; MARGEL, David; EVANS, Andrew et al.Urology (Ridgewood, NJ). 2014, Vol 83, Num 1, pp 81-87, issn 0090-4295, 7 p.Article

Association Between Germline HOXB13 G84E Mutation and Risk of Prostate CancerAKBARI, Mohammad R; TRACHTENBERG, John; LEE, Justin et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 16, pp 1260-1262, issn 0027-8874, 3 p.Article

Population based survival data on urachal tumors. CommentaryPINTHUS, Jehonathan H; HADDAD, Riad; TRACHTENBERG, John et al.The Journal of urology. 2006, Vol 175, Num 6, pp 2042-2047, issn 0022-5347, 6 p.Article

Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia : A clue to the relationship between IGF-I physiology and prostate cancer riskNAM, Robert K; TRACHTENBERG, John; JEWETT, Michael A. S et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 5, pp 1270-1273, issn 1055-9965, 4 p.Article

Do older men benefit from curative therapy of localized prostate cancer?ALIBHAI, Shabbir M. H; NAGLIE, Gary; NAM, Robert et al.Journal of clinical oncology. 2003, Vol 21, Num 17, pp 3318-3327, issn 0732-183X, 10 p.Article

Levels of insulin-like growth factor I (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrenceYU, Bert; NICAR, Michael R; SHI, Runhua et al.Urology (Ridgewood, NJ). 2001, Vol 57, Num 3, pp 471-475, issn 0090-4295Article

Luteinizing hormone-releasing hormone monotherapy: A viable option for treatment of prostate cancer? commentarySCHELLHAMMER, Paul F; FAIR, William R; TRACHTENBERG, John et al.Urology (Ridgewood, NJ). 2001, Vol 58, Num 2A, pp 10-15, issn 0090-4295Conference Paper

The role of diethylstilbestrol in the treatment of prostate cancer. CommentaryBRUCE MALKOWICZ, S; FAIR, William R; NEWLING, Don W. W et al.Urology (Ridgewood, NJ). 2001, Vol 58, Num 2A, pp 108-113, issn 0090-4295Conference Paper

Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate CancerFINELLI, Antonio; TROTTIER, Greg; JEWETT, Micheal A. S et al.European urology. 2011, Vol 59, Num 4, pp 509-514, issn 0302-2838, 6 p.Article

Clinical predictors of gleason score upgrading : Implications for patients considering watchful waiting, active surveillance, or brachytherapyKULKARNI, Girish S; LOCKWOOD, Gina; EVANS, Andrew et al.Cancer. 2007, Vol 109, Num 12, pp 2432-2438, issn 0008-543X, 7 p.Article

Evidence for a biopsy derived grade artifact among larger prostate glandsKULKARNI, Girish S; AL-AZAB, Rami; LOCKWOOD, Gina et al.The Journal of urology. 2006, Vol 175, Num 2, pp 505-509, issn 0022-5347, 5 p.Article

The use of genetic markers to determine risk for prostate cancer at prostate biopsyNAM, Robert K; ZHANG, William W; JEWETT, Michael A. S et al.Clinical cancer research. 2005, Vol 11, Num 23, pp 8391-8397, issn 1078-0432, 7 p.Article

Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detectionNAM, Robert K; ZHANG, William W; NAROD, Steven A et al.Journal of clinical oncology. 2003, Vol 21, Num 12, pp 2312-2319, issn 0732-183X, 8 p.Article

Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancerNAM, Robert K; ZHANG, William W; TOI, Ants et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 12, pp 1429-1437, issn 1055-9965, 9 p.Article

Interstitial microwave thermal therapy for prostate cancerSHERAR, Michael D; TRACHTENBERG, John; DAVIDSON, Sean R. H et al.Journal of endourology. 2003, Vol 17, Num 8, pp 617-625, issn 0892-7790, 9 p.Article

Interstitial microwave thermal therapy for prostate cancer : Method of treatment and results of a phase I/II trial. Commentary. Authors' replySHERAR, Michael D; GERTNER, Mark R; YUE, Clarence K. K et al.The Journal of urology. 2001, Vol 166, Num 5, pp 1707-1714, issn 0022-5347Article